Midostaurin for patients with acute myeloid leukemia and FLT3 mutations

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	323-325
Number of pages	3
Journal	Clinical Advances in Hematology and Oncology
Volume	17
Issue number	6
State	Published - Jun 2019

ASJC Scopus subject areas

@article{a7af753c1a0f4985a5c52946ae0f6928,

title = "Midostaurin for patients with acute myeloid leukemia and FLT3 mutations",

author = "Levis, {Mark James}",

year = "2019",

month = jun,

language = "English (US)",

volume = "17",

pages = "323--325",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "6",

}

TY - JOUR

T1 - Midostaurin for patients with acute myeloid leukemia and FLT3 mutations

AU - Levis, Mark James

PY - 2019/6

Y1 - 2019/6

UR - http://www.scopus.com/inward/record.url?scp=85071433426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071433426&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 31437132

AN - SCOPUS:85071433426

SN - 1543-0790

VL - 17

SP - 323

EP - 325

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 6

ER -